1. Allopurinol-induced SCARs and role of HLA-B*5801 genotyping

   News item 01 January 2022 Pages: 1 - 1

2. Powdered cold and flu remedies recalled in Canada

   News item 01 January 2022 Pages: 2 - 2

3. Risk of differentiation syndrome with decitabine, warns the NPRA in Malaysia

   News item 01 January 2022 Pages: 3 - 3

4. Risks associated with haloperidol use for delirium in elderly

   News item 01 January 2022 Pages: 4 - 4

5. Signal for COVID-19 vaccine-related menstrual disorders

   News item 01 January 2022 Pages: 5 - 5

6. TGA updates ceftriaxone product information to include risk of encephalopathy and hepatitis

   News item 01 January 2022 Pages: 6 - 6

7. TGA warns against buying ivermectin online from unverified sources

   News item 01 January 2022 Pages: 7 - 7

8. Venetoclax-related tumour lysis syndrome: updated recommendations

   News item 01 January 2022 Pages: 8 - 8

9. Cabozantinib associated with excessive toxicity for salivary gland cancer in phase II trial

   Clinical study 01 January 2022 Pages: 9 - 9

10. Oral contraceptive use may increase breast cancer risk

    Clinical study 01 January 2022 Pages: 10 - 10

11. Systematic review: COVID-19 vaccine-related neurological disorders "exceedingly" rare

    Clinical study 01 January 2022 Pages: 11 - 11

12. VAERS reports find no new safety concerns for Bexsero

    Clinical study 01 January 2022 Pages: 12 - 12

13. Other adverse reaction research

    News item 01 January 2022 Pages: 13 - 13

14. Immune-checkpoint-protein-inhibitors/immunosuppressants

    Case report 01 January 2022 Pages: 14 - 15

15. Abemaciclib

    Case report 01 January 2022 Pages: 15 - 15

16. Acenocoumarol/sodium-thiosulfate

    Case report 01 January 2022 Pages: 16 - 16

17. Acetazolamide

    Case report 01 January 2022 Pages: 17 - 17

18. Acetylcysteine/paracetamol

    Case report 01 January 2022 Pages: 18 - 18

19. Aciclovir

    Case report 01 January 2022 Pages: 19 - 19

20. Acitretin

    Case report 01 January 2022 Pages: 20 - 20

21. Ad26.COV2-S

    Case report 01 January 2022 Pages: 21 - 21

22. Ad26.cov2-s

    Case report 01 January 2022 Pages: 22 - 22

23. Adalimumab

    Case report 01 January 2022 Pages: 23 - 23

24. Adalimumab/infliximab/methotrexate

    Case report 01 January 2022 Pages: 24 - 24

25. Adalimumab/naproxen

    Case report 01 January 2022 Pages: 25 - 25

26. Aducanumab

    Case report 01 January 2022 Pages: 26 - 26

27. Afatinib

    Case report 01 January 2022 Pages: 27 - 27

28. Afatinib

    Case report 01 January 2022 Pages: 28 - 28

29. Afatinib

    Case report 01 January 2022 Pages: 29 - 29

30. Aflibercept/bevacizumab/ranibizumab

    Case report 01 January 2022 Pages: 30 - 30

31. Agalsidase beta

    Case report 01 January 2022 Pages: 31 - 31

32. Allopurinol/heparin/melphalan

    Case report 01 January 2022 Pages: 32 - 32

33. Alteplase

    Case report 01 January 2022 Pages: 33 - 33

34. Alteplase/enoxaparin-sodium

    Case report 01 January 2022 Pages: 34 - 34

35. Amikacin/cotrimoxazole

    Case report 01 January 2022 Pages: 35 - 35

36. Aminophylline/benralizumab

    Case report 01 January 2022 Pages: 36 - 36

37. Amiodarone

    Case report 01 January 2022 Pages: 37 - 37

38. Amiodarone/flecainide/ivabradine

    Case report 01 January 2022 Pages: 38 - 38

39. Amiodarone/ivabradine/propranolol

    Case report 01 January 2022 Pages: 39 - 39

40. Amitriptyline/nortriptyline

    Case report 01 January 2022 Pages: 40 - 40

41. Amoxicillin/clarithromycin/lansoprazole

    Case report 01 January 2022 Pages: 41 - 41

42. Amoxicillin/clavulanic-acid/cefuroxime

    Case report 01 January 2022 Pages: 42 - 42

43. Amoxicillin/clavulanic-acid/clarithromycin/tosufloxacin

    Case report 01 January 2022 Pages: 43 - 43

44. Amoxicillin/metronidazole/spiramycin

    Case report 01 January 2022 Pages: 44 - 44

45. Amphotericin B

    Case report 01 January 2022 Pages: 45 - 45

46. Amphotericin B liposomal

    Case report 01 January 2022 Pages: 46 - 46

47. Amphotericin-B-liposomal

    Case report 01 January 2022 Pages: 47 - 47

48. Amphotericin-B-liposomal/antineoplastics

    Case report 01 January 2022 Pages: 48 - 48

49. Amphotericin-B/fluconazole

    Case report 01 January 2022 Pages: 49 - 49

50. Amphotericin-b/fluconazole

    Case report 01 January 2022 Pages: 50 - 50